Anti-BCMA CAR T cells show promise in MM

被引：7
|
作者：
Peter Sidaway
机构：
来源：
Nature Reviews Clinical Oncology | 2016年 / 13卷 / 9期
关键词：
D O I：
10.1038/nrclinonc.2016.125
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：530 / 530
相关论文
共 50 条
  • [21] Allogeneic CAR T cells show promise
    Peter Sidaway
    Nature Reviews Clinical Oncology, 2022, 19 : 748 - 748
  • [22] Exhaustion and Activation Status in Apheresed T Cells Correlate with Response to Anti-BCMA CAR T Cell Therapy in Myeloma
    Wang, Meng
    Pruteanu-Malinici, Iulian
    Cohen, Adam
    Garfall, Alfred
    Tian, Lifeng
    Lacey, Simon F.
    Fraietta, Joseph
    Brogdon, Jennifer
    Davis, Megan
    Gonzalez, Vanessa
    Levine, Bruce L.
    Siegel, Donald L.
    Milone, Michael C.
    Stadtmauer, Edward A.
    June, Carl H.
    Melenhorst, J. Joseph
    MOLECULAR THERAPY, 2020, 28 (04) : 573 - 574
  • [23] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
    Zhang, Xiaohui
    Ouyang, Chenxi
    Sun, Guofeng
    Liu, Hongfeng
    Qi, Junyuan
    Suo, Xiaohui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
  • [24] Single cell Dissection of Resistance to anti-BCMA CAR-T cell Therapy
    Ledergor, Guy
    McCarthy, Elizabeth
    Shah, Nina
    Wong, Sandy
    Chang, Hewitt
    Fan, Frances
    Shao, Evans
    Gray, Lissa
    Cheung, Alexander
    Kwek, Serena
    Bylsma, Sophia
    Del Favero, Samuel
    Wustrack, Rosanna
    Spitzer, Matthew
    Wolf, Jeffrey
    Martin, Thomas
    Ye, Jimmie
    Fong, Lawrence
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E25 - E26
  • [25] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
    Yao, Xin
    Zhu, Shigui
    Huang, Jiaqi
    Qu, Xiaoyan
    Zhu, Judy
    Wei, Yutian
    Lan, Liping
    Lv, Xiaoteng
    Wu, Junfeng
    Wang, Rirfei
    Yang, Dingzhu
    Zheng, Chengxiao
    Zhao, DiJun
    Fan, Lei
    Huang, Fei
    Lu, Hua
    Zhang, Chaocan
    Chen, Cheng
    Li, Yanfeng
    Ren, Jiaqiang
    Zhang, Li
    Humphries, Michael
    Li, Jianyong
    Yao, Yihong
    BLOOD, 2019, 134
  • [26] Preclinical evaluation of CD8+ anti-BCMA mRNA CAR T cells for treatment of multiple myeloma
    Liang Lin
    Shih-Feng Cho
    Lijie Xing
    Kenneth Wen
    Yuyin Li
    Tengteng Yu
    Phillip A. Hsieh
    Hailin Chen
    Metin Kurtoglu
    Yi Zhang
    C. Andrew Stewart
    Nikhil Munshi
    Kenneth C. Anderson
    Yu-Tzu Tai
    Leukemia, 2021, 35 : 752 - 763
  • [27] Anti-BCMA CAR T-Cell Therapy in Patients with Refractory Myasthenia Gravis
    Qin, Chuan
    Tian, Dai-Shi
    Dong, Ming-Hao
    Hing, Michael
    Zhou, Luo-Qi
    Wang, Wen
    Song-Bai
    Li, Chun-Rui
    Wang, Di
    Zhang, Min
    Bu, Bi-Tao
    zu Hoerste, Gerd Meyer
    Wang, Wei
    ANNALS OF NEUROLOGY, 2024, 96 : S98 - S99
  • [28] Anti-BCMA CAR-T-cell therapy-related cardiovascular AEs
    Reactions Weekly, 2025, 2055 (1) : 7 - 7
  • [29] ANTI-BCMA CAR T-CELL THERAPY IN PATIENTS WITH REFRACTORY MYASTHENIA GRAVIS
    Tian, Dai-Shi
    Qin, Chuan
    Dong, Ming-Hao
    Heming, Michael
    Zhou, Luo-Qi
    Wang, Wen
    Cai, Song-Bai
    Li, Chun-Rui
    Wang, Di
    Zhang, Min
    Bu, Bitao
    zu Hoerste, Gerd Meyer
    Wang, Wei
    MUSCLE & NERVE, 2024, 70 (03) : 642 - 642
  • [30] Combination Anti-Bcma and Anti-CD19 CAR T Cells As Consolidation of Response to Prior Therapy in Multiple Myeloma
    Garfall, Alfred L.
    Cohen, Adam D.
    Lacey, Simon F.
    Tian, Lifeng
    Hwang, Wei-Ting
    Vogl, Dan T.
    Waxman, Adam
    Lancaster, Eric
    Nelson, Anne Marie
    Ferthio, Regina
    Fesnak, Andrew
    Lamontagne, Anne
    Brennan, Andrea
    Guilliams, Jamie
    Gladney, Whitney Lynn
    Melenhorst, J. Joseph
    Young, Regina M.
    Siegel, Don L.
    Levine, Bruce L.
    Brogdon, Jennifer
    Isaacs, Randi E.
    June, Carl H.
    Milone, Michael C.
    Stadtmauer, Edward A.
    BLOOD, 2019, 134
12345